KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Short-term Investments (2016 - 2022)

Teladoc Health (TDOC) has disclosed Short-term Investments for 8 consecutive years, with $2.5 million as the latest value for Q2 2022.

  • Quarterly Short-term Investments changed 0.04% to $2.5 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Jun 2022, changed 0.04% year-over-year, with the annual reading at $2.5 million for FY2021, 95.24% down from the prior year.
  • Short-term Investments hit $2.5 million in Q2 2022 for Teladoc Health, roughly flat from $2.5 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $54.6 million in Q1 2018 to a low of $2.5 million in Q1 2021.
  • Historically, Short-term Investments has averaged $18.9 million across 5 years, with a median of $3.1 million in 2020.
  • Biggest five-year swings in Short-term Investments: skyrocketed 1864.04% in 2020 and later plummeted 95.24% in 2021.
  • Year by year, Short-term Investments stood at $54.5 million in 2018, then plummeted by 95.03% to $2.7 million in 2019, then surged by 1864.04% to $53.2 million in 2020, then tumbled by 95.24% to $2.5 million in 2021, then rose by 0.08% to $2.5 million in 2022.
  • Business Quant data shows Short-term Investments for TDOC at $2.5 million in Q2 2022, $2.5 million in Q1 2022, and $2.5 million in Q4 2021.